ICD-10 Coding for Glioblastoma Multiforme(C71.0, C71.0B, C71.0M)
Comprehensive guide on ICD-10 coding for glioblastoma multiforme, including documentation requirements, molecular marker considerations, and common coding pitfalls.
Complete code families applicable to Glioblastoma Multiforme
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C71.0 | Malignant neoplasm of cerebrum, except lobes and ventricles | Use when glioblastoma is confirmed in the frontal lobe. |
|
| C71.9 | Malignant neoplasm of brain, unspecified | Use when glioblastoma is confirmed but the specific location is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutGlioblastoma Multiforme
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Glioblastoma Multiforme.
Omitting molecular marker status in documentation
Impact
Clinical: May affect treatment decisions and outcomes., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to incomplete documentation.
Mitigation
Ensure all molecular tests are documented., Review documentation for completeness before coding.
Coding glioblastoma without specifying IDH status
Impact
Reimbursement: May lead to incorrect DRG assignment and reimbursement issues., Compliance: Non-compliance with coding guidelines requiring molecular marker documentation., Data Quality: Inaccurate data for clinical research and treatment outcomes.
Mitigation
Ensure IDH status is documented and coded appropriately.
Incomplete Molecular Marker Documentation
Impact
Failure to document molecular markers can lead to audit findings.
Mitigation
Implement a checklist for molecular marker documentation in glioblastoma cases.